Challenges to Achieving Clinical Transplantation Tolerance

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2001 Oct 3

PMID 11581293

Citations 19

Authors

A D Salama

G Remuzzi

W E Harmon

M H Sayegh

Affiliations

Soon will be listed here.

Citing Articles

B Cell Immunity in Lung Transplant Rejection - Effector Mechanisms and Therapeutic Implications.

Ohm B, Jungraithmayr W Front Immunol. 2022; 13:845867.

PMID: 35320934 PMC: 8934882. DOI: 10.3389/fimmu.2022.845867.

Exosomes Derived from IDO1-Overexpressing Rat Bone Marrow Mesenchymal Stem Cells Promote Immunotolerance of Cardiac Allografts.

He J, Xie Q, Li B, Zhou L, Yan D Cell Transplant. 2018; 27(11):1657-1683.

PMID: 30311501 PMC: 6299201. DOI: 10.1177/0963689718805375.

Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy.

Perico N, Casiraghi F, Todeschini M, Cortinovis M, Gotti E, Portalupi V Front Immunol. 2018; 9:1359.

PMID: 29963053 PMC: 6014158. DOI: 10.3389/fimmu.2018.01359.

Mesenchymal stromal cells in renal transplantation: opportunities and challenges.

Casiraghi F, Perico N, Cortinovis M, Remuzzi G Nat Rev Nephrol. 2016; 12(4):241-53.

PMID: 26853275 DOI: 10.1038/nrneph.2016.7.

Transplantation tolerance; myth or reality?.

Vanikar A J Nephropathol. 2014; 3(1):18-21.

PMID: 24644538 PMC: 3956902. DOI: 10.12860/jnp.2014.04.

References

Strober S, Dhillon M, Schubert M, Holm B, Engleman E, Benike C . Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation. N Engl J Med. 1989; 321(1):28-33. DOI: 10.1056/NEJM198907063210106. View

Noris M, Cugini D, Casiraghi F, Azzollini N, Moraes L, Mister M . Thymic microchimerism correlates with the outcome of tolerance-inducing protocols for solid organ transplantation. J Am Soc Nephrol. 2001; 12(12):2815-2826. DOI: 10.1681/ASN.V12122815. View

Starzl T, Demetris A, Murase N, Ildstad S, Ricordi C, Trucco M . Cell migration, chimerism, and graft acceptance. Lancet. 1992; 339(8809):1579-82. PMC: 2950640. DOI: 10.1016/0140-6736(92)91840-5. View

Reinsmoen N, Matas A . Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity. Transplantation. 1993; 55(5):1017-23. DOI: 10.1097/00007890-199305000-00013. View

Kawai T, Cosimi A, Colvin R, Powelson J, Eason J, Kozlowski T . Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation. 1995; 59(2):256-62. View

Burlingham W, Grailer A, Fechner Jr J, Kusaka S, Trucco M, Kocova M . Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation. 1995; 59(8):1147-55. View

Medaer R, Stinissen P, Truyen L, Raus J, Zhang J . Depletion of myelin-basic-protein autoreactive T cells by T-cell vaccination: pilot trial in multiple sclerosis. Lancet. 1995; 346(8978):807-8. DOI: 10.1016/s0140-6736(95)91622-9. View

Hancock W, Buelow R, Sayegh M, Turka L . Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med. 1998; 4(12):1392-6. DOI: 10.1038/3982. View

Cecka J, Gjertson D, Terasaki P . Pediatric renal transplantation: a review of the UNOS data. United Network for Organ Sharing. Pediatr Transplant. 1997; 1(1):55-64. View

10.

Denton M, Magee C, Sayegh M . Immunosuppressive strategies in transplantation. Lancet. 1999; 353(9158):1083-91. DOI: 10.1016/S0140-6736(98)07493-5. View

11.

Sayegh M . Finally, CTLA4Ig graduates to the clinic. J Clin Invest. 1999; 103(9):1223-5. PMC: 408363. DOI: 10.1172/JCI6952. View

12.

Abrams J, Lebwohl M, Guzzo C, Jegasothy B, Goldfarb M, GOFFE B . CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J Clin Invest. 1999; 103(9):1243-52. PMC: 408469. DOI: 10.1172/JCI5857. View

13.

Guinan E, Boussiotis V, Neuberg D, Brennan L, Hirano N, Nadler L . Transplantation of anergic histoincompatible bone marrow allografts. N Engl J Med. 1999; 340(22):1704-14. DOI: 10.1056/NEJM199906033402202. View

14.

Kirk A, Burkly L, Batty D, Baumgartner R, Berning J, Buchanan K . Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med. 1999; 5(6):686-93. DOI: 10.1038/9536. View

15.

Watts T, DeBenedette M . T cell co-stimulatory molecules other than CD28. Curr Opin Immunol. 1999; 11(3):286-93. DOI: 10.1016/s0952-7915(99)80046-6. View

16.

Kenyon N, Chatzipetrou M, Masetti M, Ranuncoli A, Oliveira M, Wagner J . Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci U S A. 1999; 96(14):8132-7. PMC: 22200. DOI: 10.1073/pnas.96.14.8132. View

17.

Thomson A, Lu L . Dendritic cells as regulators of immune reactivity: implications for transplantation. Transplantation. 1999; 68(1):1-8. DOI: 10.1097/00007890-199907150-00001. View

18.

Contreras J, Eckhoff D, Cartner S, Frenette L, Thomas F, Robbin M . Tolerability and side effects of anti-CD3-immunotoxin in preclinical testing in kidney and pancreatic islet transplant recipients. Transplantation. 1999; 68(2):215-9. DOI: 10.1097/00007890-199907270-00009. View

19.

Anderton S, Burkhart C, Metzler B, Wraith D . Mechanisms of central and peripheral T-cell tolerance: lessons from experimental models of multiple sclerosis. Immunol Rev. 1999; 169:123-37. DOI: 10.1111/j.1600-065x.1999.tb01311.x. View

20.

Spitzer T, Delmonico F, Tolkoff-Rubin N, McAfee S, Sackstein R, Saidman S . Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation. 1999; 68(4):480-4. DOI: 10.1097/00007890-199908270-00006. View